<DOC>
	<DOCNO>NCT02052102</DOCNO>
	<brief_summary>The study hop determine whether patient left-sided breast cancer increase risk cardiac change due radiation breast +/- Anthracycline-based chemotherapy +/- Herceptin whether deep inspiration breath hold ( DIBH ) technique radiotherapy treatment would reduce dosimetric dose heart compare conventional free breathing ( FB ) technique thus reduce cardiac toxicity measure cardiac MRI use leave ventricular end-diastolic volume ( LVEDV ) metric . Bio fluid sample also collect investigate specific biomarkers breast cancer : BNP , PIIINP CITP</brief_summary>
	<brief_title>Study See Whether Breath-Hold Techniques During RT Are Effective Helping Improve Sparing Heart</brief_title>
	<detailed_description>Patients left-sided breast cancer receive adjuvant breast chest wall radiation increase risk treatment related cardiovascular morbidity . The risk cardiac morbidity mortality increase patient receives radiation follow adjuvant chemotherapy Herceptin . The dose-volume histogram ( DVH ) parameter associate increased cardiac toxicity include volume heart irradiate , total radiation dose receive left ventricle ( LV ) , V25 mean cardiac dose . Even though modern RT treatment like 3DCRT IMRT reduce mean dose heart , maximum dose left side heart/LV may reduce target close heart . The hypothesis DIBH RT safely effectively reduce heart dose , especially dose LV , could lead reduction incidence radiation induce cardiovascular morbidity mortality . Radiotherapy detrimental effect cardiac function due remodel cardiac tissue receive radiation . We believe radiation relate acute effect heart tissue detect cardiac functional MRI . The study quantify acute RT related effect . To knowledge , cardiac MRI explore non invasive technique quantify RT +/- chemotherapy related effect .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Unilateral Breast Neoplasms</mesh_term>
	<criteria>Female patient pathologically confirm left side breast cancer eligible adjuvant breast/chest wall plus minus regional nodal radiotherapy Women patient age group 18 70 year old Karnofsky performance score â‰¥ 70 Ability hold breath least 20 sec ( DIBH cohort ) Life expectancy &gt; 10 year For patient prior Anthracycline base chemotherapy Herceptin , &lt; 1.0 cm heart least 3 slice ( 3 mm slice ) FB scan , patient consider screen failure . Previously irradiate recurrent breast/chest wall tumours previous malignancy nonmelanoma skin cancer unless disease free minimum 5 year prior study entry Patients require shell breast immobilization Patients require boost Stage IV disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Deep inspiration breath hold</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>Cardiac toxicity</keyword>
	<keyword>Left-sided breast cancer</keyword>
</DOC>